Vulnerability in Oracle Life Sciences Central Designer
CVE-2026-21970
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
EPSS: 0.002 (16.0th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.
Affected products
- Oracle Life_sciences_central_designer — versions 7.0.1.0
- Oracle Corporation Life Sciences Central Designer — versions 7.0.1.0
References
- secalert_us@oracle.com (vendor-advisory, Vendor Advisory)
Frequently asked questions
- What is CVE-2026-21970?
- CVE-2026-21970 is a medium-severity vulnerability in Oracle Life Sciences Central Designer. CVSS score: 6.5/10. Published 2026-01-20.
- How severe is CVE-2026-21970?
- Medium severity. CVSS v3 base score is 6.5 out of 10.